Literature DB >> 34841210

Relationship Between COVID-19 Cases and Vaccination Rates in New York State Counties.

Halle Cerio1, Laura A Schad1, Telisa M Stewart2, Christopher P Morley3.   

Abstract

INTRODUCTION: Vaccines against SARS-CoV-2 have been developed with unprecedented speed. The phased introduction of vaccines may be serving to offset the impact of new viral variants and policy relaxation. In order to assess the impact of vaccination, we examined a snapshot of vaccination rates across counties in a single state, at a single time point, comparing them with population-adjusted case counts.
METHODS: We calculated descriptive statistics and bivariate correlations for vaccination rates and cases across counties in New York State (NYS). We conducted a linear regression using cases/100K population per NYS county, frozen at a single snapshot in time, as the outcome variable, predicted by percentage of each county's population (completed series/two doses), controlling for county population.
RESULTS: Percentages with one dose and with two doses were highly correlated (r=.935, P<.001) with one another. Both the one dose and two dose z rates were negatively correlated with cases per 100K population (not significant). Population size was strongly correlated with cases per 100K (r=.715, P<.001). The two-dose vaccination rate was a significant negative predictor of cases per 100K population in NYS counties (β= -.866, P=.031), with each percentage point of completed vaccination nearly equating to one case less in the daily count when controlling for county population size (β =2.732, P<.001).
CONCLUSION: While variants may impact vaccine effectiveness, current vaccination efforts are helping forestall some cases in NYS. Widespread vaccination is still an important goal. Primary care providers, public officials, and public health scientists should continue to urgently promote and support vaccination efforts.
© 2021 by the Society of Teachers of Family Medicine.

Entities:  

Year:  2021        PMID: 34841210      PMCID: PMC8612591          DOI: 10.22454/PRiMER.2021.432215

Source DB:  PubMed          Journal:  PRiMER        ISSN: 2575-7873


  9 in total

1.  Covid-19: New coronavirus variant is identified in UK.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2020-12-16

2.  Social Distancing Metrics and Estimates of SARS-CoV-2 Transmission Rates: Associations Between Mobile Telephone Data Tracking and R.

Authors:  Christopher P Morley; Kathryn B Anderson; Jana Shaw; Telisa Stewart; Stephen J Thomas; Dongliang Wang
Journal:  J Public Health Manag Pract       Date:  2020 Nov/Dec

3.  Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.

Authors:  Bhavini Patel Murthy; Natalie Sterrett; Daniel Weller; Elizabeth Zell; Laura Reynolds; Robin L Toblin; Neil Murthy; Jennifer Kriss; Charles Rose; Betsy Cadwell; Alice Wang; Matthew D Ritchey; Lynn Gibbs-Scharf; Judith R Qualters; Lauren Shaw; Kathryn A Brookmeyer; Heather Clayton; Paul Eke; Laura Adams; Julie Zajac; Anita Patel; Kimberley Fox; Charnetta Williams; Shannon Stokley; Stephen Flores; Kamil E Barbour; LaTreace Q Harris
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-05-21       Impact factor: 17.586

4.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

5.  SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.

Authors:  Michael A Johansson; Talia M Quandelacy; Sarah Kada; Pragati Venkata Prasad; Molly Steele; John T Brooks; Rachel B Slayton; Matthew Biggerstaff; Jay C Butler
Journal:  JAMA Netw Open       Date:  2021-01-04

6.  County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.

Authors:  Michelle M Hughes; Alice Wang; Marissa K Grossman; Eugene Pun; Ari Whiteman; Li Deng; Elaine Hallisey; J Danielle Sharpe; Emily N Ussery; Shannon Stokley; Trieste Musial; Daniel L Weller; Bhavini Patel Murthy; Laura Reynolds; Lynn Gibbs-Scharf; LaTreace Harris; Matt D Ritchey; Robin L Toblin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-26       Impact factor: 17.586

7.  Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

Authors:  Cheryl Keech; Gary Albert; Iksung Cho; Andreana Robertson; Patricia Reed; Susan Neal; Joyce S Plested; Mingzhu Zhu; Shane Cloney-Clark; Haixia Zhou; Gale Smith; Nita Patel; Matthew B Frieman; Robert E Haupt; James Logue; Marisa McGrath; Stuart Weston; Pedro A Piedra; Chinar Desai; Kathleen Callahan; Maggie Lewis; Patricia Price-Abbott; Neil Formica; Vivek Shinde; Louis Fries; Jason D Lickliter; Paul Griffin; Bethanie Wilkinson; Gregory M Glenn
Journal:  N Engl J Med       Date:  2020-09-02       Impact factor: 91.245

8.  SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

Authors:  Aziz Sheikh; Jim McMenamin; Bob Taylor; Chris Robertson
Journal:  Lancet       Date:  2021-06-14       Impact factor: 79.321

9.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Eileen Gallagher; Ruth Simmons; Simon Thelwall; Julia Stowe; Elise Tessier; Natalie Groves; Gavin Dabrera; Richard Myers; Colin N J Campbell; Gayatri Amirthalingam; Matt Edmunds; Maria Zambon; Kevin E Brown; Susan Hopkins; Meera Chand; Mary Ramsay
Journal:  N Engl J Med       Date:  2021-07-21       Impact factor: 91.245

  9 in total
  1 in total

1.  The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan.

Authors:  Sawsan Abuhammad; Omar F Khabour; Karem H Alzoubi; Shaher Hamaideh; Baker A Alzoubi; Waed S Telfah; Farah K El-Zubi
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.